Bumper Offer - Urjas oil Just @ Rs. 1
Glevo is a prescription medicine that is available as a Tablet, Drops, Infusion. Primarily, it is used for the treatment of Urinary Tract Infection, Prostatitis, Pneumonia. Secondary and off-label uses of Glevo have also been mentioned below.
The correct dosage of Glevo depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Glevo as well, which are listed below. Usually, these side effects of Glevo go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
In addition, Glevo's effect is Moderate during pregnancy and Severe for lactating mothers. Warnings related to Glevo's effects on the liver, heart and kidney, if any, have been listed below.
Glevo is not recommended if you suffer from certain medical conditions as it can have adverse effects. Coronary Artery Disease (CAD), Heart Disease, Myasthenia Gravis (MG) are examples of such conditions. Some other conditions that can be affected by Glevo are listed in the contraindications section below.
Additionally, Glevo may also adversely react with other medicines. Refer to the list below for further details.
You should also be aware that Glevo is not safe while driving, and is not addiction.
Glevo is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Glevo is used -
Severe
Moderate
Mild
Is the use of Glevo safe for pregnant women?
Pregnant women may experience moderate side effects from Glevo. It is best to stop taking Glevo immediately and inform your doctor if you notice any discomfort.
Is the use of Glevo safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Glevo. So it is adviced to consult the doctor before using it.
What is the effect of Glevo on the Kidneys?
Glevo rarely affects the kidneys.
What is the effect of Glevo on the Liver?
There are no any side effects of Glevo on the liver.
What is the effect of Glevo on the Heart?
There are no any side effects of Glevo for the heart.
Glevo should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Glevo unless your doctor advises you to do so -
Is this Glevo habit forming or addictive?
No, you will not get addicted to Glevo.
Is it safe to drive or operate heavy machinery when consuming?
After taking Glevo you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, Glevo is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, the use of Glevo in mental disorders is not effective.
Interaction between Food and Glevo
Taking Glevo with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Glevo
Drinking alcohol while taking Glevo may lead to slight side effects. If you experience any side effects, contact your doctor.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Levaquin® (levofloxacin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 713
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1399
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Levaquin® (levofloxacin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 713
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1399
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Levaquin® (levofloxacin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 713
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1399
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Levaquin® (levofloxacin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 713
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1399
